Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Pharma (IGC) over the last 17 years, with Q3 2025 value amounting to -$896000.0.

  • Pharma's Other Working Capital Changes fell 92201.83% to -$896000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 83137.25%. This contributed to the annual value of $187000.0 for FY2025, which is 22466.67% up from last year.
  • As of Q3 2025, Pharma's Other Working Capital Changes stood at -$896000.0, which was down 92201.83% from -$183000.0 recorded in Q2 2025.
  • Pharma's Other Working Capital Changes' 5-year high stood at $167000.0 during Q1 2021, with a 5-year trough of -$896000.0 in Q3 2025.
  • Its 5-year average for Other Working Capital Changes is -$105631.6, with a median of -$33000.0 in 2023.
  • In the last 5 years, Pharma's Other Working Capital Changes surged by 45757.58% in 2024 and then plummeted by 92201.83% in 2025.
  • Over the past 5 years, Pharma's Other Working Capital Changes (Quarter) stood at $36000.0 in 2021, then tumbled by 438.89% to -$122000.0 in 2022, then rose by 23.77% to -$93000.0 in 2023, then soared by 60.22% to -$37000.0 in 2024, then tumbled by 2321.62% to -$896000.0 in 2025.
  • Its Other Working Capital Changes stands at -$896000.0 for Q3 2025, versus -$183000.0 for Q2 2025 and -$3000.0 for Q1 2025.